NP2 Enkephalin For Treatment of Intractable Cancer Pain
Phase 2
Completed
- Conditions
- Intractable PainNeoplasms
- Interventions
- Biological: PlaceboBiological: NP2
- First Posted Date
- 2011-02-09
- Last Posted Date
- 2014-08-08
- Lead Sponsor
- Diamyd Inc
- Target Recruit Count
- 33
- Registration Number
- NCT01291901
- Locations
- 🇺🇸
Arizona Clinical Research Center, Tucson, Arizona, United States
🇺🇸Compassionate Cancer Care Medical Group, Inc., Corona, California, United States
🇺🇸Hematology Oncology Associates, Oakland, California, United States
Gene Transfer for Cancer Pain
Phase 1
Completed
- Conditions
- Cancer Pain
- Interventions
- Biological: NP2
- First Posted Date
- 2008-12-08
- Last Posted Date
- 2014-02-19
- Lead Sponsor
- Diamyd Inc
- Target Recruit Count
- 10
- Registration Number
- NCT00804076
- Locations
- 🇺🇸
Center for Clinical Research, Winston-Salem, North Carolina, United States
🇺🇸University of Michigan Medical Center, Ann Arbor, Michigan, United States
🇺🇸Advanced Pharma CR, Miami, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath